New anti-inflammatory treatments using synthetic galectin assemblies
Synthetic Multivalent Galectin Assemblies as Anti-Inflammatory Therapies
This study is exploring a new way to help people with chronic inflammation by creating a special treatment that uses natural proteins to reduce inflammation more effectively and with fewer side effects than traditional medications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10991404 on NIH RePORTER |
What this research studies
This research focuses on developing innovative therapies to treat chronic inflammatory conditions that affect millions of Americans. It aims to create synthetic multivalent assemblies of galectin-1 and galectin-3, which are natural regulators of inflammation, to enhance their effectiveness. By using a localized delivery method, the research seeks to minimize the side effects associated with conventional anti-inflammatory drugs. The approach involves creating a novel compound called G1/G3 Zipper, which has shown promising results in laboratory tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with chronic inflammatory conditions who have not responded well to conventional anti-inflammatory treatments.
Not a fit: Patients with acute inflammatory conditions or those who do not have chronic inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and safer treatment option for patients suffering from chronic inflammatory conditions.
How similar studies have performed: Previous research has shown some success with natural galectins as anti-inflammatory agents, but this approach of synthetic multivalent assemblies is relatively novel.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Hudalla, Gregory — University of Florida
- Study coordinator: Hudalla, Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.